Accès gratuit
Numéro
Med Sci (Paris)
Volume 18, Numéro 12, Décembre 2002
Page(s) 1195 - 1196
Section Le Magazine : Nouvelles
DOI https://doi.org/10.1051/medsci/200218121195
Publié en ligne 15 décembre 2002
  1. Mulsant P, Lecerf F, Fabre S, et al. Mutation in bone morphogenetic protein receptor-IB is associated with increased ovulation rate in Booroola Merinos ewes. Proc Natl Acad Sci USA 2001; 98: 5104–9.
  2. Wilson T, Wu XY, Juengel JL, et al. Highly prolific Booroola sheep have a mutation in the intracellular kinase domaine of bone morphogenetic protein IB receptor (ALK-6) that is expressed in both oocytes and granulosa cells. Biol Reprod 2001; 64: 1225–35.
  3. Souza CJH, MacDouglas C, Campbell BK, McNeilly AS, Baird DT. The Booroola phenotype is associated with a mutation in the bone morphogenetic receptor type IB (BMPR1B) gene. J Endocrinol 2001; 169: R1–6.
  4. Galloway SM, McNatty KP, Cambridge LM, et al. Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner. Nat Genet 2000; 25: 279–83.
  5. Miyazono K, Kusanagi K, Inoue H. Divergence and convergence of TGF-β/BMP signaling. J Cell Physiol 2001; 187: 265–76.
  6. Monget P, Fabre S, Mulsant P, et al. Regulation of ovarian folliculogenesis by IGF and BMP system in domestic animals. Domest Anim Endocrinol 2002; 23: 139–54.
  7. Yi SE, LaPolt PS, Yoon BS, Chen JY, Lu JK, Lyons KM. The type I BMP receptor BmprIB is essential for female reproductive function. Proc Natl Acad Sci USA 2001; 98: 7994–9.
  8. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 1996; 383: 531–5.
  9. Vitt UA, McGee EA, Hayashi M, Hsuchi AJ. In vitro treatment with GDF9 stimulates primordial and primary follicle progression and theca cell marker CYP17 in ovary of immature rats. Endocrinology 2000; 141: 3814–20.
  10. Yan C, Wang P, Demayo J, et al. Synergistic roles of bone morphogenetic protein 15 and growth differentiation factor 9 in ovarian function. Mol Endocrinol 2001; 15: 854–66.
  11. Teixeira Filho FL, Bacarat EC, Lee TH, et al. Aberrant expression of growth differentiation factor-9 in oocytes of women with polycystic ovary syndrome. J Clin Endocrinol Metab 2002; 87: 1337–44.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.